C.R. Bard Inc (BCR)

BCR (NYSE:Health Services) EQUITY
$211.05
pos +2.30
+1.10%
Today's Range: 206.71 - 211.47 | BCR Avg Daily Volume: 523,200
Last Update: 12/07/16 - 1:22 PM EST
Volume: 232,146
YTD Performance: 10.19%
Open: $208.24
Previous Close: $208.74
52 Week Range: $172.21 - $239.43
Oustanding Shares: 73,526,324
Market Cap: 15,455,968,568
6-Month Chart
TheStreet Ratings Grade for BCR
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 2 2 2 1
Moderate Buy 1 1 1 1
Hold 11 11 12 12
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.64 2.64 2.67 2.79
Latest Dividend: 0.26
Latest Dividend Yield: 0.49%
Dividend Ex-Date: 10/20/16
Price Earnings Ratio: 31.37
Price Earnings Comparisons:
BCR Sector Avg. S&P 500
31.37 31.40 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-5.99% 11.27% 51.88%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.80 0.10 0.05
Net Income -54.00 -0.70 -0.36
EPS -52.90 -0.70 -0.34
Earnings for BCR:
EBITDA 1.04B
Revenue 3.42B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $2.74 $2.61 $10.26 $11.42
Number of Analysts 13 6 13 13
High Estimate $2.75 $2.70 $10.27 $11.55
Low Estimate $2.71 $2.54 $10.23 $11.26
Prior Year $2.43 $2.34 $9.08 $10.26
Growth Rate (Year over Year) 12.69% 11.47% 13.00% 11.34%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

bullishCR Bard upgraded at BMO

Oct 26, 2016 | 7:07 AM EDT
BCR was upgraded from Market Perform to Outperform, BMO Capital said. Valuation call, based on a $240 price target.
By

Tim Melvin

 | Sep 13, 2016 | 2:00 PM EDT
These sectors are full of high-priced, low-growth stocks.
RMPIA
By

Jim Cramer

 | Aug 29, 2016 | 6:00 AM EDT
The leadership is quite stark.
RMPIA
By

Jim Cramer

 | Jul 18, 2016 | 6:00 AM EDT
Let me give you the unassailable themes.
By

Jim Cramer

 | Jun 13, 2016 | 7:20 AM EDT

There is so much buying power in so many new areas.

By

Bruce Kamich

 | Jun 6, 2016 | 2:40 PM EDT

Traders should look to go long BCR near $210 if it pulls back.

By

Bruce Kamich

 | Jan 29, 2016 | 11:19 AM EST

Buyers should stay on the sidelines of Bard until a base is formed, potentially at a lower level.

By

Thomas Ward

 | Jan 23, 2016 | 12:00 PM EST

Two significant, but subtle forces may threaten the group in the next 12 months.

By

Bruce Kamich

 | Dec 18, 2015 | 9:11 AM EST

We would begin trimming our position with a stop-loss just below $180.

By

Bruce Kamich

 | Oct 5, 2015 | 12:30 PM EDT

With no top in sight, we remain bulls on this name.

This stock is having a strong day with great volume, good flow lately (Feb 140 strikes) an...
This chart is starting to break out nicely, outside day here. BOUGHT DG JAN 77.5 CALL A...
Market mixed with NASDAQ down a good amount.  Biotech down 3% as it is the "Trump Spe...
We bought some calls yesterday and rolled up.  This chart is fantastic, I'll have tha...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.